GOLT1B and breast cancer: In terms of tumor subtypes, compared with luminal breast cancers, triple-negative type showed higher expression of GOLT1B (P < 0.0001), indicating that GOLT1B might be correlated with tumor malignancy (Supplementary Figure S2E).